Bank of America’s Cyclerion Therapeutics CYCN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70 | Buy |
24
+5
| +26% | +$15 | ﹤0.01% | 6995 |
|
|
2025
Q1 | $48 | Hold |
19
| – | – | ﹤0.01% | 6935 |
|
|
2024
Q4 | $62 | Sell |
19
-4
| -17% | -$13 | ﹤0.01% | 6903 |
|
|
2024
Q3 | $59 | Buy |
23
+7
| +44% | +$18 | ﹤0.01% | 6880 |
|
|
2024
Q2 | $37 | Buy |
+16
| New | +$37 | ﹤0.01% | 7001 |
|
|
2023
Q1 | – | Sell |
-48
| Closed | -$31 | – | 7001 |
|
|
2022
Q4 | $31 | Buy |
48
+47
| +4,700% | +$30 | ﹤0.01% | 7068 |
|
|
2022
Q3 | $0 | Sell |
1
-28
| -97% | – | ﹤0.01% | 6971 |
|
|
2022
Q2 | $0 | Sell |
29
-2,442
| -99% | – | ﹤0.01% | 7186 |
|
|
2022
Q1 | $3K | Buy |
2,471
+2,004
| +429% | +$2.43K | ﹤0.01% | 7147 |
|
|
2021
Q4 | $1K | Sell |
467
-55
| -11% | -$118 | ﹤0.01% | 7164 |
|
|
2021
Q3 | $2K | Sell |
522
-5,493
| -91% | -$21K | ﹤0.01% | 6961 |
|
|
2021
Q2 | $23K | Sell |
6,015
-26,487
| -81% | -$101K | ﹤0.01% | 6273 |
|
|
2021
Q1 | $90K | Buy |
32,502
+16,667
| +105% | +$46.2K | ﹤0.01% | 5758 |
|
|
2020
Q4 | $48K | Buy |
15,835
+5,765
| +57% | +$17.5K | ﹤0.01% | 5582 |
|
|
2020
Q3 | $61K | Sell |
10,070
-5,569
| -36% | -$33.7K | ﹤0.01% | 5293 |
|
|
2020
Q2 | $93K | Buy |
15,639
+4,994
| +47% | +$29.7K | ﹤0.01% | 5142 |
|
|
2020
Q1 | $28K | Sell |
10,645
-1,938
| -15% | -$5.1K | ﹤0.01% | 5456 |
|
|
2019
Q4 | $34K | Sell |
12,583
-6,893
| -35% | -$18.6K | ﹤0.01% | 5532 |
|
|
2019
Q3 | $236K | Sell |
19,476
-13,040
| -40% | -$158K | ﹤0.01% | 4783 |
|
|
2019
Q2 | $372K | Buy |
+32,516
| New | +$372K | ﹤0.01% | 4540 |
|